Galaxy, a domestic artificial intelligence new drug development company (CEO Cha-ok Seok), and LG Chem signed a joint research agreement on the 23rd to develop anticancer drugs using new drug design ...

K-MEDI Hub (Daegu-Gyeongbuk Medical Innovation Foundation, Chairman Yang Jin-young) and Daewoong Pharmaceutical (CEOs Jeon Seung-ho and Lee Chang-jae) began joint research on the development of ...

Daewoong Pharmaceutical will unveil its cancer drug new drug pipeline. All three new drugs are "innovative drugs" that treat cancer through new processes that have not existed before. Daewoong ...

Circulating tumor cells (CTCs) are rare cells found in peripheral blood of metastatic cancer patients. Analysis of CTCs has clinical potentials of cancer patient prognosis and therapeutic effects of ...

SEOUL, South Korea, April 30, 2025 /PRNewswire/ -- J INTS BIO, a company specializing in anticancer and orphan drugs, announced its research findings for the next-generation EGFR-TKI therapeutic ...

Lunit said on the 16th that it signed a collaboration agreement with Japanese drugmaker Daiichi Sankyo to develop new cancer drugs. Under the agreement, Daiichi Sankyo will work with Lunit on drug ...

'JIN-A02': New Hope for Overcoming Resistance – 4th Generation EGFR-TKI Clinical Results Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases worldwide, and among ...

The global Anticancer Drug Market is witnessing a powerful wave of innovation, driven by breakthroughs in precision oncology, rising cancer incidence, and strong investments in research and ...

Race identifies primary mechanism of action for (E,E)-bisantrene (RCDS1), the active compound underpinning its lead candidate RC220 drug Targeting G4-DNA and RNA structures by RCDS1 reduces the ...

Indian pharmaceutical companies are increasingly investing in anticancer research and drug innovation as part of their strategy for future growth. With the global oncology market expected to expand ...